Last10K.com

Tauriga Sciences, Inc. (TAUG) SEC Filing 10-K Annual report for the fiscal year ending Sunday, March 31, 2019

SEC Filings

Tauriga Sciences, Inc.

HISTORY TOOLS
CIK: 759944 Ticker: TAUG
Document and Entity Information - USD ($)
12 Months Ended
Mar. 31, 2019
Jun. 26, 2019
Sep. 28, 2018
Document And Entity Information   
Entity Registrant NameTAURIGA SCIENCES, INC.  
Entity Central Index Key0001142790  
Document Type10-K  
Document Period End DateMar. 31, 2019  
Amendment Flagfalse  
Current Fiscal Year End Date--03-31  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilerNo  
Entity Reporting Status CurrentYes  
Entity Interactive Data CurrentNo  
Entity Filer CategoryNon-accelerated Filer  
Entity Small Business Flagtrue  
Entity Emerging Growth Companyfalse  
Entity Ex Transition Periodfalse  
Entity Shell Companyfalse  
Entity Public Float  $ 1,350,492
Entity Common Stock, Shares Outstanding 72,925,920 
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2019  

View differences made from one year to another to evaluate Tauriga Sciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Tauriga Sciences, Inc..

Continue

Assess how Tauriga Sciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Tauriga Sciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statement Of Stockholders' Equity (Deficit)
Consolidated Statement Of Stockholders' Equity (Deficit) (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Basis Of Operations
Basis Of Operations (Details Narrative)
Commitments
Commitments (Details Narrative)
Concentrations
Concentrations (Details Narrative)
Derivative Liabilities Embedded In Convertible Notes
Derivative Liabilities Embedded In Convertible Notes (Details Narrative)
Discontinued Operations
Discontinued Operations (Details Narrative)
Discontinued Operations (Tables)
Discontinued Operations - Summary Of Discontinued Operations (Details)
Fair Value Measurements
Fair Value Measurements (Tables)
Fair Value Measurements - Summary Of Company's Financial Assets And Liabilities Measured At Fair Value On Recurring Basis (Details)
Intangible Assets
Intangible Assets (Details Narrative)
Inventory
Inventory (Details Narrative)
Inventory (Tables)
Inventory - Schedule Of Inventory (Details)
Investments
Investments (Details Narrative)
Investments (Tables)
Investments - Schedule Of Investment In Trading Securities (Details)
Investments - Schedule Of Investment In Trading Securities (Details) (Parenthetical)
Litigation
Litigation (Details Narrative)
Notes Payable To Individuals And Companies
Notes Payable To Individuals And Companies (Details Narrative)
Notes Payable To Individuals And Companies (Tables)
Notes Payable To Individuals And Companies - Schedule Of Notes Payable To Individuals And Companies (Details)
Notes Payable To Individuals And Companies - Schedule Of Notes Payable To Individuals And Companies (Details) (Parenthetical)
Property And Equipment
Property And Equipment (Details Narrative)
Property And Equipment (Tables)
Property And Equipment - Schedule Of Property And Equipment (Details)
Provision For Income Taxes
Provision For Income Taxes (Details Narrative)
Provision For Income Taxes (Tables)
Provision For Income Taxes - Schedule Of Deferred Tax Assets (Details)
Provision For Income Taxes - Schedule Of Effective Income Tax Rate (Details)
Related Parties
Related Parties (Details Narrative)
Stockholders' Equity (Deficit)
Stockholders' Equity (Deficit) (Details Narrative)
Stockholders' Equity (Deficit) (Tables)
Stockholders' Equity (Deficit) - Schedule Of Assumptions Under Black-Scholes Pricing Model (Details)
Stockholders' Equity (Deficit) - Schedule Of Stock Options Activity (Details)
Stockholders' Equity (Deficit) - Schedule Of Warrants Activity (Details)
Subsequent Events
Subsequent Events (Details Narrative)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details Narrative)
Summary Of Significant Accounting Policies (Policies)
Ticker: TAUG
CIK: 1142790
Form Type: 10-K Annual Report
Accession Number: 0001493152-19-009783
Submitted to the SEC: Thu Jun 27 2019 10:03:21 AM EST
Accepted by the SEC: Thu Jun 27 2019
Period: Sunday, March 31, 2019
Industry: Medicinal Chemicals And Botanical Products

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/taug/0001493152-19-009783.htm